Nature's Sunshine Products, Inc. (NATR) Insider Trading Activity

NASDAQ$25.06
Market Cap
$438.44M
Sector
Consumer Defensive
Industry
Packaged Foods
Rank in Sector
132 of 170
Rank in Industry
41 of 47

NATR Insider Trading Activity

NATR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$33,524,587
9
100

Related Transactions

Norman Daniel CEVP & President, Asia
0
$0
1
$181,767
$-181,767
Lanoy Jonathan DavidSVP, Chief Accounting Officer
0
$0
2
$184,800
$-184,800
Yates Bryant JEVP & President, Europe
0
$0
3
$199,812
$-199,812
Brower Nathan GEVP, General Counsel
0
$0
2
$244,412
$-244,412
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
0
$0
1
$32.71M
$-32.71M

About Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

Insider Activity of Nature's Sunshine Products, Inc.

Over the last 12 months, insiders at Nature's Sunshine Products, Inc. have bought $0 and sold $33.52M worth of Nature's Sunshine Products, Inc. stock.

On average, over the past 5 years, insiders at Nature's Sunshine Products, Inc. have bought $201,080 and sold $8.74M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $44,675 was made by WYNNEFIELD PARTNERS SMALL CAP VALUE LP (10 percent owner) on 2022‑09‑15.

List of Insider Buy and Sell Transactions, Nature's Sunshine Products, Inc.

2025-12-12SaleYates Bryant JEVP & President, Europe
1,700
0.0095%
$22.29
$37,893
+7.03%
2025-11-18SaleLanoy Jonathan DavidSVP, Chief Accounting Officer
5,000
0.0281%
$20.45
$102,250
+8.74%
2025-11-14SaleBrower Nathan GEVP, General Counsel
3,800
0.0218%
$20.81
$79,078
+6.47%
2025-11-12SaleNorman Daniel CEVP & President, Asia
8,884
0.0578%
$20.46
$181,767
+8.60%
2025-08-29SaleYates Bryant JEVP & President, Europe
4,672
0.0263%
$16.71
$78,069
+24.99%
2025-08-26SaleYates Bryant JEVP & President, Europe
5,000
0.029%
$16.77
$83,850
+26.91%
2025-08-13SaleLanoy Jonathan DavidSVP, Chief Accounting Officer
5,000
0.0279%
$16.51
$82,550
+23.75%
2025-08-13SaleBrower Nathan GEVP, General Counsel
9,996
0.0559%
$16.54
$165,334
+23.75%
2025-06-27SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
2.85M
12.2196%
$11.46
$32.71M
+17.93%
2024-10-15SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
2,300
0.012%
$13.02
$29,946
+13.82%
2024-10-14SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
1,300
0.0068%
$13.12
$17,056
+12.90%
2024-10-11SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
1,580
0.0084%
$13.37
$21,125
+11.62%
2024-10-10SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
3,000
0.0161%
$13.39
$40,170
+9.50%
2024-10-09SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
1,816
0.0097%
$13.36
$24,262
+9.91%
2024-10-08SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
1,800
0.0094%
$13.13
$23,634
+11.46%
2024-10-01SaleShanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
1,399
0.0076%
$13.54
$18,942
+9.77%
2024-06-06SaleYates Bryant JEVP & President, Europe
3,068
0.0163%
$15.30
$46,940
-6.78%
2023-11-30SaleNorman Daniel CEVP & President, Asia
13,000
0.0682%
$17.06
$221,780
-6.60%
2023-11-29SaleNorman Daniel CEVP & President, Asia
2,000
0.0107%
$17.59
$35,180
-7.32%
2023-11-21SaleBrower Nathan GEVP, General Counsel
3,999
0.021%
$17.31
$69,223
-6.78%
Total: 408
*Gray background shows transactions not older than one year

Insider Historical Profitability

3.36%
Yates Bryant JEVP & President, Europe
98604
0.5636%
$2.47M011
Norman Daniel CEVP & President, Asia
66636
0.3809%
$1.67M011
Brower Nathan GEVP, General Counsel
46735
0.2671%
$1.17M06
Lanoy Jonathan DavidSVP, Chief Accounting Officer
46233
0.2643%
$1.16M02
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.10 percent owner
0
0%
$008
WYNNEFIELD PARTNERS SMALL CAP VALUE LP10 percent owner
1699139
9.7118%
$42.58M1180
+3.41%
LANDES JOSHUA
1695708
9.6922%
$42.49M50
+4.17%
DELTA PARTNERS LLC10 percent owner
1551970
8.8706%
$38.89M1032
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10 percent owner
1499404
8.5702%
$37.58M11
<0.0001%
WEIR CANDACE Kdirector
1387100
7.9283%
$34.76M07
PROBERT GREGORYCEO & Chairman of the Board
199394
1.1397%
$5M210
<0.0001%
FAGGIOLI DOUGLASPresident and CEO
114436
0.6541%
$2.87M03
MESDAG WILLEM10 percent owner
104036
0.5946%
$2.61M150
+5.24%
HUGHES EUGENE LSPOUSE
79352
0.4536%
$1.99M060
HUGHES KRISTINE Fdirector
74062
0.4233%
$1.86M035
Bunker Stephen MEVP, CFO & Treasurer
31839
0.182%
$797,885.3446
+31.95%
HUFF CRAIG DEVP & CFO
7000
0.04%
$175,420.0004
Dean MichaelPresident and CEO
4000
0.0229%
$100,240.0020
+7.55%
LEE DALE GEVP & President US Sales
3005
0.0172%
$75,305.3002
DEWYZE JOHN REVP, VP - Operations
2150
0.0123%
$53,879.0007
DOWDEN ALBERT Rdirector
1000
0.0057%
$25,060.0010
+48.73%
Mercer Robert Bdirector
1000
0.0057%
$25,060.0010
+0.97%
HOGGE DAREN GEVP, President - Int'l. Div.
0
0%
$008
FRANCIS PAULINE HUGHES
0
0%
$0014
HINCKLEY RICHARD Gdirector
0
0%
$001
Jarvis JamonEVP, Gen Counsel, Sec, CCO
0
0%
$0012
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Nature's Sunshine Products, Inc.
(NATR)
$45,235,911
167
3.36%
$438.44M
$542,136,648
146
8.87%
$61.98M
$934,184,897
112
16.85%
$1.6B
$101,983,535
96
25.36%
$764.47M
$5,929,392
73
24.76%
$62.43M
$10,226,898
68
9.73%
$1.93B
$6,583,432
41
10.36%
$437.47M
$74,373,768
39
-2.02%
$377.62M
$15,487,425
36
11.89%
$325.95M
$24,914,584
33
24.00%
$1.52B
$20,006,286
33
8.69%
$1.64B
$28,922,382
28
23.44%
$900.76M
$1,680,244
27
10.94%
$964.45M
$32,609,414
27
37.83%
$323.61M
$2,333,703
26
11.01%
$757.87M
$39,991
13
-0.80%
$64.63M
$4,423,449
12
-9.45%
$244.54M
$2,912,100
7
43.17%
$359.59M
$831,335
4
-8.75%
$2.06B

NATR Institutional Investors: Active Positions

Increased Positions84+70.59%1M+9.02%
Decreased Positions48-40.34%1M-7.98%
New Positions32New553,958New
Sold Out Positions9Sold Out544,398Sold Out
Total Postitions155+30.25%15M+1.04%

NATR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Wynnefield Capital Inc$51,873.0014.55%2.47M00%2025-09-30
Prescott Group Capital Management, L.L.C.$37,392.0010.49%1.78M00%2025-09-30
Blackrock, Inc.$21,951.006.16%1.05M+99,062+10.45%2025-09-30
Dimensional Fund Advisors Lp$19,162.005.38%913,791+20,037+2.24%2025-09-30
Vanguard Group Inc$16,841.004.72%803,104+106,688+15.32%2025-09-30
Kennedy Capital Management Llc$14,171.003.98%675,764+86,128+14.61%2025-09-30
Acadian Asset Management Llc$11,623.003.26%554,248-3,921-0.7%2025-09-30
Renaissance Technologies Llc$10,636.002.98%507,197+5,400+1.08%2025-09-30
American Century Companies Inc$8,309.002.33%396,210+62,054+18.57%2025-09-30
Geode Capital Management, Llc$7,519.002.11%358,566+40,835+12.85%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.